The State Food and Drug Administration (SFDA) recently released the 2011 Annual Report on Drug Registration Approval. The Annual Report is composed of six sections, including the approval for drug production and marketing, the approval for drug clinical research, the drug registration application acceptance, the approval for drugs used in key therapeutic areas, the measures for enhancing drug registration management and the future work.
SFDA releases 2011 Annual Report on Drug Registration Approval
- SFDA Deputy Commissioner Bian Zhenjia meets Deputy Commissioner of US FDA
- SFDA issues notice on standardizing the labels and packaging marks of foreign medical devices
- SFDA Commissioner Yin Li meets the delegation from Center for Genetic Engineering and Biotechnology of Cuba
- SFDA issues the Guide for the Application and Review of Children's Cosmetics
- SFDA issues Guiding Opinions on Electronic Supervision of Drugs
- SFDA releases 2011 Annual Report on Drug Registration Approval
- SFDA Commissioner Yin Li meets the delegation of Roszdravnadzor
- New version of EN ISO 14971:2012 was published
- New version of EN ISO 13485:2012 was published
- Transition from ISO 19011:2002 to a new version ISO 19011:2011